Viewing nowCombinationPimaten Tablet 30/2.5 mg
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.

MFDS item code 202300082 · Approved 2023.01.06
Improvement of blood pressure control in essential hypertension
Used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with pimasartan potassium.
Take 1 tablet once daily with water, regardless of meals. It is recommended to take it at the same time each day if possible. If blood pressure is not controlled with 30 mg of pimasartan monotherapy, take 30/2.5 mg. If blood pressure is not controlled with 60 mg of pimasartan monotherapy, take 60/2.5 mg. Take either 60 mg of pimasartan monotherapy or 60/2.5 mg.
Safety and efficacy in pediatric and adolescent patients under 18 years of age have not been established.
This medication may cause serious harm to the fetus and newborn when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be taken by individuals allergic to the active ingredient or similar components. Women who are pregnant or breastfeeding, patients undergoing kidney dialysis, patients with severe liver impairment, and those with certain conditions such as biliary obstruction should not use this medication. Particular caution is needed when using this medication in patients with low blood volume or decreased sodium, impaired kidney function, renal artery hypertension, severe hypotension, the elderly, etc. Rarely, side effects may include dizziness, headaches, facial swelling, urinary disturbances, insomnia, and flushing. Blood pressure may drop too low; therefore, careful monitoring is necessary when starting or increasing the dosage. Periodic monitoring of serum potassium levels is advisable while taking this medication. Consultation with a doctor or pharmacist is required when taken with other antihypertensive agents, diuretics, potassium-sparing diuretics, some antibiotics, and anti-inflammatory medications due to potential interactions. Use during pregnancy or breastfeeding is not recommended; if necessary, consult a specialist. Safety has not been established for children and adolescents under 18 years of age. In case of overdose, severe hypotension or cardiac issues may occur, so the dosage must be strictly adhered to, and if unusual symptoms arise, immediate medical attention is necessary. This medication should be kept out of reach of children and should not be transferred to other containers.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, lightning-like headaches, seizures, confusion, visual disturbances, paralysis, urination.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, the medication is best kept at room temperature between 1 degree and 30 degrees Celsius, avoiding extremely hot or cold locations.
White, round-edged square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aprogen BioLogic Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.